147 related articles for article (PubMed ID: 2297240)
1. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers].
Nakashima T; Tomita K; Kuratomi Y; Maehara Y; Kohnoe S
Gan To Kagaku Ryoho; 1990 Jan; 17(1):79-84. PubMed ID: 2297240
[TBL] [Abstract][Full Text] [Related]
2. [Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer--chemosensitivity test and a comparative study with doxorubicin].
Nakashima T; Masuda A; Yano G; Maehara Y
Gan To Kagaku Ryoho; 1994 Apr; 21(5):633-9. PubMed ID: 8154889
[TBL] [Abstract][Full Text] [Related]
3. [The sensitivity of 1,000 human tumors to antitumor drugs using the succinate dehydrogenase inhibition (SDI) test].
Miyamoto K; Fukuchi K
Rinsho Byori; 1990 Nov; 38(11):1273-8. PubMed ID: 2273570
[TBL] [Abstract][Full Text] [Related]
4. Succinate dehydrogenase inhibition test for evaluating head and neck tumors.
Nakashima T; Uemura T; Maehara Y; Sugimachi K
Oncology; 1989; 46(3):162-8. PubMed ID: 2717126
[TBL] [Abstract][Full Text] [Related]
5. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer.
Kusumoto H; Maehara Y; Kusumoto T; Anai H; Akazawa K; Sugimachi K
Eur J Surg Oncol; 1988 Dec; 14(6):685-9. PubMed ID: 3192005
[TBL] [Abstract][Full Text] [Related]
7. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas.
Nakashima T; Maehara Y; Kohnoe S; Hayashi I; Katsuta Y
Head Neck; 1990; 12(5):406-10. PubMed ID: 2211101
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test.
Mitsudomi T; Kaneko S; Tateishi M; Yano T; Ishida T; Kohnoe S; Maehara Y; Sugimachi K
Anticancer Res; 1990; 10(4):987-90. PubMed ID: 2382998
[TBL] [Abstract][Full Text] [Related]
9. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues.
Takeuchi H; Baba H; Inutsuka S; Takahashi I; Kusumoto H; Maehara Y; Sugimachi K
Anticancer Res; 1994; 14(1A):169-71. PubMed ID: 8166444
[TBL] [Abstract][Full Text] [Related]
10. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay].
Suzuki K; Fujii M; Ishii Y; Mochizuki F; Suzuki K; Yamagata M; Suzuki H; Moriya Y; Abiko Y; Sakabe T
Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric DNA analysis and chemosensitivity in squamous cell carcinoma of the head and neck].
Miyagi M; Soda T; Nakashima T
Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2247-58. PubMed ID: 7861297
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
13. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
15. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
16. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
18. 4'-O-tetrahydropyranyladriamycin has greater antineoplastic activity than adriamycin in various human tumours in vitro.
Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
Anticancer Res; 1989; 9(2):387-9. PubMed ID: 2751263
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test].
Saito H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests].
Saeki T; Jinushi K; Kim R; Kirihara Y; Takagami S; Nishiyama M; Saeki K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1989 May; 16(5):2025-30. PubMed ID: 2730092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
